BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 23, 1994
View Archived Issues
IBEX LICENSES ENZYME TECHNOLOGY FROM MCGILL
Read More
PHASE II BASAL CELL CANCER TRIALS YIELD 91 PERCENT RESPONSE RATE
Read More
TEST SHOWS BENEFIT OF BIOMUNE'S DRUG
Read More
CYTEL GETS $3M INVESTMENT FROM JAPANESE DRUG COMPANY
Read More
CAMBRIDGE NEUROSCIENCE ADVANCES CERESTAT STUDY
Read More
D. BLECH CRISIS SLAMS STOCKS
Read More
HOUSE MINORITY WHIP WANTS MAJOR OVERHAUL FOR FDA
Read More
TRACKING THE AFTERBIRTH GENE FROM MOUSE TO HUMAN
Read More